Converts liquid formulations into dry powders for drug development and scale-up
Specialist dealers — search these first
EquipNet
Global marketplace for process and pilot equipment
Surplus Solutions
Pharma and biotech process equipment specialists
BioSurplus
Life science surplus — curated biotech gear
Heritage Global
Pharma facility liquidation auctions
LabX
Lab equipment marketplace — dealer + private listings
Kitmondo
Used process and laboratory equipment, EU focus
eBay rarely carries pilot-scale equipment at this quality level. Specialist dealers above are the primary market.
Live listings for GEA Niro · Mobile Minor
Not ready to buy yet?
Set a target price — we'll email when a match appears on eBay.
Not sure what to buy?
Pilot scale purchases are high-stakes. I can help you evaluate specific listings, assess GMP documentation, and identify the right seller.
Get free advice →Before you buy — what to inspect
Büchi units dominate the used pharmaceutical spray dryer market and retain excellent value due to robust Swiss engineering, worldwide service network, and extensive documentation. B-290 (current model) and B-191/B-190 (predecessors) share similar architecture and performance. The B-290 added integrated dehumidifier and modernized controls but B-191 remains highly capable. Most used Büchi spray dryers come from pharmaceutical labs upgrading to larger capacity or CDMOs consolidating equipment. Expect complete service records and batch documentation. Key advantage: Büchi maintains parts availability for equipment 20+ years old and offers retrofit packages to upgrade controls and add 21 CFR Part 11 compliance ($15,000-$25,000). Typical useful life exceeds 25 years with proper maintenance. Buy from pharmaceutical facilities, not universities—pharma units have superior maintenance history.
Checklist: Verify nozzle condition (two-fluid nozzle tips wear and affect spray pattern—replacement $800-$1,200), inspect dehumidifier compressor operation if equipped (compressor replacement $4,000-$6,000), test all heating zones individually (6 heating zones typical, each element $500-$800), examine cyclone and glassware for chips or cracks (replacement cyclone $3,000-$5,000, glassware set $2,000-$4,000), verify aspiration rate and pressure drop indicates clean filters (new filter set $600-$1,000), and obtain calibration certificates for all sensors dated within 12 months
GEA (formerly Niro Atomizer) invented spray drying technology and manufactures both pilot and production equipment. The Mobile Minor is a true pharmaceutical pilot dryer (5-10 kg/h evaporation) designed for tech transfer to GEA production systems—this is the gold standard if you plan to eventually manufacture at scale with GEA. PSD-1 is compact pilot model (1-3 kg/h) well-suited for formulation development. All GEA pilot units feature heavy-duty construction, excellent process control, and comprehensive documentation. These are industrial-grade machines built for 24/7 operation, significantly overbuilt for typical pilot use—will last decades. Drawback: service can be expensive as GEA focuses on large production equipment and treats pilots as entry points. Used units typically come from pharmaceutical companies that shut down R&D facilities or CDMOs upgrading capacity. Expect to pay for GEA service contracts ($10,000-$20,000/year) if you want responsive support.
Checklist: GEA units use rotary atomizers—inspect atomizer wheel for erosion, check bearing play and vibration (wheel replacement $8,000-$15,000, bearing service $3,000-$5,000), test all interlocks and safety systems thoroughly (GEA implements extensive interlocking that can be complicated to troubleshoot), verify bag filter housing integrity and pulse-jet cleaning system (bag set $2,000-$4,000), inspect all welds on chamber for cracks (full chamber refurbishment $25,000-$40,000 if needed), and obtain complete drawing set including P&IDs and electrical schematics (essential for maintaining these complex systems)
SPX (formerly Anhydro, now part of SPX FLOW) manufactures pharmaceutical pilot dryers designed for seamless scale-up to their production systems. Lab S1 is compact pilot unit (2-5 kg/h evaporation) with excellent solvent handling capability and closed-loop design. These units are extremely well-engineered but less common in US market—SPX has stronger presence in Europe and Asia. Used units occasionally appear from multinational pharma companies. Advantage: if your target production site has SPX equipment, pilot data directly transfers. Challenge: US service requires coordination with SPX's pharmaceutical processing group in Denmark—response times can be slow and parts expensive due to international shipping. Documentation quality is excellent for GMP compliance.
Checklist: Inspect closed-loop nitrogen system components including condenser, chiller interface, and nitrogen makeup regulator (condenser tube leaks are common failure point—retube costs $8,000-$12,000), verify all explosion-proof ratings are current with certification documentation, test control system thoroughly as older SPX units used proprietary systems that are difficult to support (control retrofit $25,000-$45,000 if needed), examine all gaskets in solvent-contact areas (organic solvents degrade seals faster than water-based systems), and verify feed pump capability with viscous fluids if doing polymer work (upgrade to progressive cavity pump $5,000-$8,000 if needed)
Belgian manufacturer ProCepT (formerly Zelva) produces innovative pharmaceutical spray dryers focused on nano-particle production and advanced formulation. The 4M8-TriX is unique in offering three-fluid nozzle atomization for nanospray applications, making it valuable for amorphous solid dispersion and nano-crystalline drug development. These are specialized units that command premium prices when new ($150,000-$200,000) but depreciate steeply because they serve niche applications. If your work involves poorly soluble APIs and you need <500nm particles, ProCepT technology is superior to conventional spray dryers. Used units are rare but occasionally available from pharma companies that completed specific development programs. Service is through ProCepT's network—responsive but parts can take 6-8 weeks from Belgium.
Checklist: Three-fluid nozzle is complex and expensive ($3,000-$5,000 replacement)—inspect for wear and test spray pattern, verify high-pressure pump operation (10-20 bar typical) and check seals/pistons, examine chamber design which differs from conventional spray dryers (more compact, different gas flow patterns), ensure laser diffraction or other particle size analyzer is available to verify system performance (ProCepT units are optimized for specific particle size ranges), and obtain application data from previous use to understand if unit is configured for your target particle size
Japanese manufacturer with 85+ year history in spray drying technology. Ohkawara pilot dryers are well-built, reliable machines common in Japanese pharmaceutical companies and increasingly found in US through acquisitions and partnerships. L-8i is compact pilot model (0.5-1.5 kg/h) with clean design and good process control. OC-16 is larger pilot/small production unit (3-8 kg/h). Strengths: robust mechanical design, excellent temperature uniformity, and competitive pricing when new. Weaknesses: English documentation can be limited, US service network is thin (mostly through importers and third-party service providers), and control systems use Japanese PLC platforms that US technicians may be unfamiliar with. Used units occasionally appear from site closures but buyer should verify they can obtain ongoing technical support.
Checklist: Verify availability of English manuals and electrical/P&ID drawings (Japanese documentation requires translation), test control system and identify PLC model—determine if you can source a US-based programmer familiar with the platform (Mitsubishi and Omron PLCs are common but may use Japanese firmware), inspect atomization system as Ohkawara uses proprietary nozzle designs—confirm you can source replacements, verify heating elements and temperature sensors are standard components (some older units use Japan-specific voltage/frequency equipment—conversion adds cost), and consider budgeting for control system replacement ($20,000-$35,000) to standardize on US platforms if integration with facility systems is required
Budget new alternatives
Academic labs and early-stage biotech doing formulation feasibility without immediate GMP requirements
Mid-size pharma or biotech labs seeking reliable pilot dryer at 25-30% savings versus top-tier brands
A pharmaceutical pilot-scale spray dryer is a continuous processing unit that transforms liquid feeds into dry powder through atomization and rapid evaporation. The process involves pumping liquid feed through a nozzle (pressure, two-fluid, or rotary atomizer) that creates a spray of fine droplets. These droplets contact heated drying gas (typically air or nitrogen for oxygen-sensitive compounds) in a drying chamber, where moisture evaporates almost instantaneously. The resulting dry particles are separated from the exhaust gas using cyclones and/or bag filters. Pilot-scale units typically process 1-10 kg/hour of solvent and produce 0.1-2 kg/hour of powder, making them ideal for process development, stability studies, toxicology batches, and Phase I/II clinical supplies. Modern pharmaceutical spray dryers operate in closed-loop or semi-closed configurations for solvent recovery and offer precise control over inlet/outlet temperatures, atomization parameters, and drying gas flow to control particle size distribution, morphology, and moisture content. The technology is particularly valuable for producing amorphous solid dispersions to enhance bioavailability of poorly water-soluble drugs, creating inhalable powders with specific aerodynamic properties, microencapsulating APIs for controlled release, and improving powder flow and stability characteristics. GMP-compliant pilot spray dryers feature cleanable construction with sanitary fittings, documentation packages including FAT/SAT protocols, and validation support for regulatory submissions.
Büchi B-290 is the de facto standard for pharmaceutical pilot spray drying globally, installed in hundreds of pharma R&D labs and CDMOs. The system features a compact tall-form design with 0.5-1.0 kg/h water evaporation capacity, two-fluid nozzle atomization with precise control, inlet temperatures up to 220°C, and high-performance cyclone plus electrostatic precipitator for >98% product recovery. The integrated dehumidifier enables low-temperature drying (inlet 40-50°C) for heat-sensitive biologics and provides exceptional control over outlet conditions regardless of ambient humidity. Büchi's global service network, extensive application database, and regulatory support documentation make it the safe choice for validated pharmaceutical environments. The B-290 produces 50-500g batches typical for formulation development and early clinical supplies. Control system offers full data logging, recipe management, and optional 21 CFR Part 11 compliance package. Used units from reputable pharmaceutical sites retain high value due to Büchi's build quality and long service life—most remain productive after 15-20 years with proper maintenance.
What you lose: Budget or lower-tier pilot spray dryers sacrifice automation sophistication (manual parameter adjustment vs. recipe-driven operation, limited data logging, no 21 CFR Part 11 compliance), process control precision (±5°C temperature control vs. ±1-2°C, less precise atomization leading to wider particle size distributions), product recovery efficiency (85-90% recovery vs. >95%, meaning material waste and longer cleaning), documentation quality (minimal IQ/OQ protocols vs. comprehensive validation packages with application data), service support (limited US presence, slow parts delivery, minimal technical expertise vs. worldwide networks with pharmaceutical specialists), and advanced features (no integrated dehumidifier for low-temperature drying, no closed-loop solvent capability, basic cyclone separation vs. cyclone plus electrostatic precipitator or bag filter). Budget units are adequate for feasibility studies and formulation screening but struggle to generate the reproducible, well-characterized data needed for regulatory submissions and tech transfer to manufacturing. Expect to spend 20-30% more staff time troubleshooting process variability and dealing with equipment issues. For high-value pharmaceutical development where API costs $10,000-$50,000/kg and clinical timelines are critical, the incremental cost of premium equipment is easily justified by improved productivity and data quality.
What you keep: You retain the core spray drying functionality: conversion of liquid formulations to dry powder with control over basic process parameters (inlet/outlet temperature, atomization pressure, feed rate). Budget equipment uses the same fundamental physics and achieves similar particle formation mechanisms. You can still produce material suitable for early formulation studies, conduct scale-down experiments to understand production processes, evaluate particle morphology and solid-state properties, and generate preliminary stability data. Mechanically, even budget spray dryers use stainless steel construction adequate for pharmaceutical materials (though perhaps 304 vs. 316L), achieve sterile operation if proper cleaning procedures are followed, and produce powder quality acceptable for non-clinical testing. The basic spray drying learning curve and process understanding development occurs equivalently on any equipment—expensive automation doesn't teach you formulation science. For research groups focused on understanding spray drying fundamentals, optimizing formulation composition, or generating proof-of-concept data for grant applications and early partnership discussions, budget equipment delivers 80% of the value at 40-50% of the cost. The limitation is scale-up predictability and validated production capability, not basic pharmaceutical powder production.
Pharmaceutical spray dryers for clinical manufacturing must comply with cGMP requirements including design qualification (DQ), installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). Specify 316L stainless steel contact parts with sanitary finish (Ra ≤0.8 μm), sloped surfaces for complete drainage, and tri-clamp connections for disassembly. CIP capability is highly desirable but not always required for pilot scale—manual cleaning with validated procedures is acceptable. Control system must provide audit trails, electronic signatures, and secure data storage per 21 CFR Part 11. All instruments (temperature sensors, pressure transmitters, flow meters) require calibration certificates traceable to NIST standards. For product-contact surfaces, cleaning validation studies should demonstrate removal of API to <10 ppm residue or 0.001% of minimum therapeutic dose. If processing potent compounds (OEL <10 μg/m³), containment measures including closed loading/unloading, negative pressure operation, and HEPA-filtered exhaust are required. Document all design features supporting GMP compliance in a Design Qualification document. Expect regulatory agencies to scrutinize particle size distribution control, batch-to-batch reproducibility, and demonstration of process scale-up relationships to commercial equipment. For DEA-controlled substances, additional security and accountability measures are mandatory.